Exchange Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Exchange Capital Management, Inc.

$593 Million
Q3 2024

A detailed history of Exchange Capital Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 46,627 shares of GILD stock, worth $4.33 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

46,627

Previous 36,812 26.66%

Holding current value

$4.33 Million

Previous $2.53 Million 54.77%

% of portfolio

0.66%

Previous 0.42%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $653,580 - $824,361	9,815 Added 26.66%	46,627 $3.91 Million
Q2 2024 Jul 23, 2024	SELL	$63.15 - $72.88 $39,658 - $45,768	-628 Reduced 1.68%	36,812 $2.53 Million
Q1 2024 Apr 18, 2024	BUY	$71.58 - $87.29 $25,053 - $30,551	350 Added 0.94%	37,440 $2.74 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $47,625 - $54,008	-650 Reduced 1.72%	37,090 $3 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $247,403 - $269,921	3,346 Added 9.73%	37,740 $2.83 Million
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $4,940 - $5,635	-65 Reduced 0.19%	34,394 $2.65 Million
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $23,193 - $26,424	300 Added 0.88%	34,459 $2.86 Million
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $53,283 - $76,496	-855 Reduced 2.44%	34,159 $2.93 Million
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $27,269 - $31,148	-458 Reduced 1.29%	35,014 $2.16 Million
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $12,987 - $14,627	-225 Reduced 0.63%	35,472 $2.19 Million
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $1,100 - $1,379	-19 Reduced 0.05%	35,697 $2.12 Million
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $1,946 - $2,209	-30 Reduced 0.08%	35,716 $2.59 Million
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $113,786 - $122,763	1,681 Added 4.93%	35,746 $2.5 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $209,197 - $228,577	3,296 Added 10.71%	34,065 $2.35 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $214,200 - $244,402	3,570 Added 13.13%	30,769 $1.99 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $723,023 - $823,851	12,763 Added 88.41%	27,199 $1.59 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $109,668 - $137,889	1,766 Added 13.94%	14,436 $912,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $10,851 - $12,600	150 Added 1.2%	12,670 $975,000
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $784,127 - $1 Million	12,520 New	12,520 $936,000
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $12,108 - $15,800	-200 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$71.28 - $78.92 $14,256 - $15,784	200 New	200 $15,000
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $4,006 - $4,884	-55 Closed	0 $0
Q4 2017 May 07, 2018	SELL	$71.15 - $83.52 $5,336 - $6,264	-75 Reduced 57.69%	55 $4,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $9,374 - $11,111	130	130 $11,000

Others Institutions Holding GILD

# of Institutions

1,939

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Gilead Sciences, Inc. Transaction History